期刊文献+

天然型EGFP在无细胞翻译系统中的可溶表达 被引量:1

Soluble expression of native EGFP in a cell-free translation system
在线阅读 下载PDF
导出
摘要 目的:构建能在无细胞翻译系统中表达天然型增强绿色荧光蛋白(EGFP)的原核表达载体。方法:以质粒pEGFP-N1为模板扩增EGFP基因,NcoI和HindⅢ双酶切EGFP基因和pET28a载体。T4 DNA连接酶连接,转化E.coliDH5α,提取载体,酶切和DNA测序鉴定。正确重组的载体命名为pET28a-EGFP。在无细胞翻译系统中加入大抽后的pET28a-EGFP模板(0.6 mg/ml),孵育3 h。荧光显微镜观察荧光。Western blot鉴定EGFP。结果:测序证实重组EGFP基因序列与基因库中的序列完全一致,荧光显微镜下观察到无细胞翻译系统中强烈荧光,Western blot证实分子量约为27 kD的EGFP高效表达。结论:成功构建了能在无细胞翻译系统中高效表达可溶性天然型EGFP的pET28a-EGFP载体,为进一步建立荧光强度标准物奠定了基础。 Objective: To construct the prokaryotic expression plasmid that can express enhanced green fluorescent protein(EGFP) in a cell-free translation system. Methods: Utilizing plasmid as template, full-length EGFP gene was amplified. The pEGFP-N1 gene digested with NcoⅠ, Hind Ⅲ was ligated to pET28a vector and digested with the same restriction enzymes, then the resultant ligation product was transformed into E. coli DHSα. Positive clones were propagated and recombinant plasmids were extracted for further identification and sequencing. The sequence-confirmed recombinant plasmid was then given the name, pET28a-EGFP. The macroprepared pET28a-EGFP (0.6mg/ml) was added into the Cell-Free translation system,and incubated for 3 hours. The fluorescence was observed by the fluorescence microscopy. EGFP was identified by Western blotting. Results: DNA sequencing confirmed that the EGFP gene sequence in pET28a-EGFP was in accordance with that of GenBenk. The intensive fluorescence in cell-free translation system was seen under the fluorescence microscope. Western blotting demonstrated that expressed protein of about 27000 was native EGFP. Conclusion: The pET28a-EGFP which can efficiently express the soluble native EGFP in cell-free translation system was successfully constructed, which provided a basis to further establish a standard substance of fluorescence intensity.
出处 《江苏大学学报(医学版)》 CAS 2007年第3期225-227,231,共4页 Journal of Jiangsu University:Medicine Edition
关键词 增强绿色荧光蛋白(EGFP) 重组载体 无细胞翻译系统 原核表达 enhanced green fluorescent protein (EGFP) recombinant plasmid cell-free translation system prokaryotic expression
  • 相关文献

参考文献9

  • 1Hechler D,Nitsch R,Hendrix S.Green-fluorescent-protein-expressing mice as models for the study of axonal growth and regeneration in vitro[J].Brain Res Rev,2006,52(1):160-169.
  • 2Schwartz A,Gaigalas AK,Wang L,et al.Formalization of the MESF unit of fluorescence intensity[J].Cytometry B Clin Cytom,2004,57(1):1-6.
  • 3Kay S,Herishanu Y,Pick M,et al.Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome[J].Cytometry B Clin Cytom,2006,70(4):218-226.
  • 4Wang L,Abbasi F,Gaigalas AK,et al.Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells[J].Cytometry B Clin Cytom,2006,70(6):410-415.
  • 5Kar-Roy A,Dong W,Michael N,et al.Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1[J].J Virol Methods,2000,84(2):127-138.
  • 6Gerena-Lopez Y,Nolan J,Wang J,et al.Quantification of EGFP expression on Molt-4 cells using calibration standards[J].Cytometry A,2004,60(1):21-28.
  • 7Yang TT,Cheng L,Kain SR.Optimized codon usage and chromophere mutations provide enhanced sensitivity with the green fluorescent protein[J].Nucleic Acids Res,1996,24(22):4592-4593.
  • 8Yang TT,Kain SR,Kitts P,et al.Dual color microscopic imagery of cell expressing the green fluorescent protein and a red-shifted variant[J].Gene,1996,173:19-23.
  • 9Baranov VI,Spirin AS.Gene expression in cell-free system on preparative scale[J].Meth Enzymol,1993,217:123-142.

同被引文献24

  • 1刘原照.α-干扰素在肿瘤治疗中的应用[J].中国处方药,2004,3(7):36-38. 被引量:5
  • 2李茜,杜永忠,袁弘,等.RGD肽在肿瘤靶向纳米给药系统中的应用[J].海峡医学,2011,23(6):80-82.
  • 3白启柴.肾癌根治性切除术后联合应用α-干扰素的疗效观察[J].全科医师临床与教育,2007,5(4):291-292,295.
  • 4Sharma MK, Gour N, Pandey A, et al. Epidemiological trends of cancer morbidity at a government medical college hospital, Chandigarh, India[J]. Asian Pac J Cancer Prev, 2012, 13(7) : 3061 - 3064.
  • 5Rodl W, Schaffert D, Wagner E, et al. Synthesis of polyethylenimine-based nanocarriers for systemic tumor targeting of nucleic acids [J]. Methods Mol Biol, 2013, 948:105 -120.
  • 6Hensing TA. Clinical evaluation and staging of patients who have lung cancer [ J 1. Hematol Oncol Clin North Am, 2005, 19 (2) : 219 - 235.
  • 7Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment[J]. Urol Oncol, 2008, 26(1) : 57 -64.
  • 8Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines : Principles and practice [ J ]. Br J Cancer, 2008, 99 ( 3 ) : 392 - 397.
  • 9Shuhendler AJ, Prasad P, Leung M, et al. A novel solid lipid nano- particle formulation for active targeting to tumor α(v)β(3) integrin receptors reveals cyclic RGD as a double-edged sword [ J ]. Adv Healthc Mater, 2012, 1 (5): 600-608.
  • 10Sheldrake HM, Patterson LH. Function and antagonism of beta3 integrins in the development of cancer therapy[ J]. Curr Cancer Drug Targets, 2009, 9(4) : 519 -540.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部